Nerve ultrasound in clinical management of carpal tunnel syndrome in mucopolysaccharidosis

Dev Med Child Neurol. 2016 Nov;58(11):1172-1179. doi: 10.1111/dmcn.13127. Epub 2016 Apr 21.

Abstract

Aim: Mucopolysaccharidoses (MPS) are a group of diseases with an almost 100% lifetime incidence of carpal tunnel syndrome (CTS) in MPSsubtypes I, II, and VI. We compared nerve ultrasound with clinical signs and electrophysiology in a clinical setting to screen for CTSin MPS.

Method: Twenty-four patients (13 male, 11 female, mean age of 7y 11mo [SD8y 5mo], range 6mo-29y) were screened for CTS. Eight of these patients were re-examined post-operatively. Clinical signs, distal motor latency, compound muscle action potential, sensory nerve action potential amplitude and velocity, as well as echogenicity and the cross-sectional area (CSA) of the median nerve at the wrist and forearm determined with ultrasound were assessed and the wrist to forearm ratio (WFR) calculated. Eighteen healthy participants formed a comparison group, who were also investigated with nerve ultrasound.

Results: In 26% of the patients' hands, clinical signs of CTSwere present; 77% fulfilled electrophysiological and 92% nerve ultrasound criteria for CTS. Post-operatively, electrophysiology improved significantly, whereas ultrasound results were unchanged. In the comparison group, age and height correlated with the CSA, but not with WFR.

Interpretation: Nerve ultrasound is a useful and painless primary screening tool for CTSin MPS.

MeSH terms

  • Adolescent
  • Adult
  • Carpal Tunnel Syndrome / diagnostic imaging*
  • Carpal Tunnel Syndrome / etiology
  • Carpal Tunnel Syndrome / physiopathology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Median Nerve / diagnostic imaging*
  • Mucopolysaccharidoses / complications*
  • Neural Conduction / physiology
  • Ultrasonography / methods
  • Ultrasonography / standards*
  • Young Adult